生物活性植物成分通过调节炎症和脂肪生成途径对肥胖相关的非酒精性脂肪肝具有改善作用:综述

IF 7.3 2区 生物学 Q1 PLANT SCIENCES
Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak
{"title":"生物活性植物成分通过调节炎症和脂肪生成途径对肥胖相关的非酒精性脂肪肝具有改善作用:综述","authors":"Pervej Alom Barbhuiya,&nbsp;Saikat Sen,&nbsp;Manash Pratim Pathak","doi":"10.1007/s11101-023-09912-w","DOIUrl":null,"url":null,"abstract":"<div><p>By 2025, the projected global obesity rates for both men and women are 18% and 21%, respectively. Obesity raises the risk of several comorbidities like cardiovascular disease, gastrointestinal disorders, type 2 diabetes, respiratory problems, and most importantly non-alcoholic fatty liver disease (NAFLD). NAFLD is commonly considered to be both a consequence and a contributor to metabolic dysfunctions such as obesity, given the liver’s pivotal role in metabolism. NAFLD is a range of disease phenotypes that initiate hepatocyte inflammation and lipid accumulation owing to de novo lipogenesis (DNL). NAFLD has the potential to advance to non-alcoholic steatohepatitis, marked by hepatic fibrosis and the subsequent emergence of NAFLD-associated cirrhosis and hepatocellular carcinoma. Several notable biomarkers, including C-reactive protein, tumour necrosis factor-α, interleukin-6, leptin, fatty acid synthase and sterol regulatory element binding protein-1c have been found to have a direct correlation with inflammation and DNL. Several research studies have provided evidence regarding the effectiveness and safety of plant derived bioactive compounds plants for managing obesity associated NAFLD. Several bioactive phytoconstituents like antcin A, ginsenoside, naringenin, apigenin, silibinin, kaempferol have been identified as potential agents for improving obesity associated NAFLD by targeting the inflammatory and DNL pathways. This review explores the connection between inflammation and DNL in the development of obesity-associated NAFLD by discussing a few biomarkers related to both the hallmarks and some novel avenues for addressing the treatment of NAFLD in individuals with obesity. Besides, this review provides an overview of the efficacy of different bioactive phytoconstituents in combating obesity associated NAFLD by targeting the inflammatory and DNL pathways.</p></div>","PeriodicalId":733,"journal":{"name":"Phytochemistry Reviews","volume":"23 4","pages":"969 - 996"},"PeriodicalIF":7.3000,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review\",\"authors\":\"Pervej Alom Barbhuiya,&nbsp;Saikat Sen,&nbsp;Manash Pratim Pathak\",\"doi\":\"10.1007/s11101-023-09912-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>By 2025, the projected global obesity rates for both men and women are 18% and 21%, respectively. Obesity raises the risk of several comorbidities like cardiovascular disease, gastrointestinal disorders, type 2 diabetes, respiratory problems, and most importantly non-alcoholic fatty liver disease (NAFLD). NAFLD is commonly considered to be both a consequence and a contributor to metabolic dysfunctions such as obesity, given the liver’s pivotal role in metabolism. NAFLD is a range of disease phenotypes that initiate hepatocyte inflammation and lipid accumulation owing to de novo lipogenesis (DNL). NAFLD has the potential to advance to non-alcoholic steatohepatitis, marked by hepatic fibrosis and the subsequent emergence of NAFLD-associated cirrhosis and hepatocellular carcinoma. Several notable biomarkers, including C-reactive protein, tumour necrosis factor-α, interleukin-6, leptin, fatty acid synthase and sterol regulatory element binding protein-1c have been found to have a direct correlation with inflammation and DNL. Several research studies have provided evidence regarding the effectiveness and safety of plant derived bioactive compounds plants for managing obesity associated NAFLD. Several bioactive phytoconstituents like antcin A, ginsenoside, naringenin, apigenin, silibinin, kaempferol have been identified as potential agents for improving obesity associated NAFLD by targeting the inflammatory and DNL pathways. This review explores the connection between inflammation and DNL in the development of obesity-associated NAFLD by discussing a few biomarkers related to both the hallmarks and some novel avenues for addressing the treatment of NAFLD in individuals with obesity. Besides, this review provides an overview of the efficacy of different bioactive phytoconstituents in combating obesity associated NAFLD by targeting the inflammatory and DNL pathways.</p></div>\",\"PeriodicalId\":733,\"journal\":{\"name\":\"Phytochemistry Reviews\",\"volume\":\"23 4\",\"pages\":\"969 - 996\"},\"PeriodicalIF\":7.3000,\"publicationDate\":\"2023-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Reviews\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s11101-023-09912-w\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PLANT SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Reviews","FirstCategoryId":"99","ListUrlMain":"https://link.springer.com/article/10.1007/s11101-023-09912-w","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PLANT SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

预计到 2025 年,全球男性和女性的肥胖率将分别达到 18% 和 21%。肥胖会增加多种并发症的风险,如心血管疾病、胃肠道疾病、2 型糖尿病、呼吸系统疾病,以及最重要的非酒精性脂肪肝(NAFLD)。鉴于肝脏在新陈代谢中的关键作用,非酒精性脂肪肝通常被认为是肥胖等代谢功能障碍的后果和诱因。非酒精性脂肪肝(NAFLD)是由于新生脂肪生成(DNL)而引发肝细胞炎症和脂质蓄积的一系列疾病表型。非酒精性脂肪肝有可能发展为以肝纤维化为特征的非酒精性脂肪性肝炎,随后出现非酒精性脂肪肝相关性肝硬化和肝细胞癌。研究发现,包括 C 反应蛋白、肿瘤坏死因子-α、白细胞介素-6、瘦素、脂肪酸合成酶和固醇调节因子结合蛋白-1c 在内的几种著名生物标志物与炎症和 DNL 直接相关。多项研究证明,植物提取的生物活性化合物对控制肥胖相关的非酒精性脂肪肝具有有效性和安全性。一些具有生物活性的植物成分,如安替比林 A、人参皂甙、柚皮苷、芹菜素、丝核苷、山柰酚等,已被确定为通过靶向炎症和 DNL 途径改善肥胖相关性非酒精性脂肪肝的潜在药物。本综述通过讨论与肥胖相关的非酒精性脂肪肝标志物相关的一些生物标志物以及治疗肥胖症患者非酒精性脂肪肝的一些新途径,探讨了肥胖相关的非酒精性脂肪肝发病过程中炎症和 DNL 之间的联系。此外,本综述还概述了不同的生物活性植物成分通过靶向炎症和DNL途径防治肥胖相关性非酒精性脂肪肝的功效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review

Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review

By 2025, the projected global obesity rates for both men and women are 18% and 21%, respectively. Obesity raises the risk of several comorbidities like cardiovascular disease, gastrointestinal disorders, type 2 diabetes, respiratory problems, and most importantly non-alcoholic fatty liver disease (NAFLD). NAFLD is commonly considered to be both a consequence and a contributor to metabolic dysfunctions such as obesity, given the liver’s pivotal role in metabolism. NAFLD is a range of disease phenotypes that initiate hepatocyte inflammation and lipid accumulation owing to de novo lipogenesis (DNL). NAFLD has the potential to advance to non-alcoholic steatohepatitis, marked by hepatic fibrosis and the subsequent emergence of NAFLD-associated cirrhosis and hepatocellular carcinoma. Several notable biomarkers, including C-reactive protein, tumour necrosis factor-α, interleukin-6, leptin, fatty acid synthase and sterol regulatory element binding protein-1c have been found to have a direct correlation with inflammation and DNL. Several research studies have provided evidence regarding the effectiveness and safety of plant derived bioactive compounds plants for managing obesity associated NAFLD. Several bioactive phytoconstituents like antcin A, ginsenoside, naringenin, apigenin, silibinin, kaempferol have been identified as potential agents for improving obesity associated NAFLD by targeting the inflammatory and DNL pathways. This review explores the connection between inflammation and DNL in the development of obesity-associated NAFLD by discussing a few biomarkers related to both the hallmarks and some novel avenues for addressing the treatment of NAFLD in individuals with obesity. Besides, this review provides an overview of the efficacy of different bioactive phytoconstituents in combating obesity associated NAFLD by targeting the inflammatory and DNL pathways.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Phytochemistry Reviews
Phytochemistry Reviews PLANT SCIENCES-
CiteScore
16.30
自引率
2.60%
发文量
54
审稿时长
2 months
期刊介绍: Phytochemistry Reviews is the sole review journal encompassing all facets of phytochemistry. It publishes peer-reviewed papers in six issues annually, including topical issues often stemming from meetings organized by the Phytochemical Society of Europe. Additionally, the journal welcomes original review papers that contribute to advancing knowledge in various aspects of plant chemistry, function, biosynthesis, effects on plant and animal physiology, pathology, and their application in agriculture and industry. Invited meeting papers are supplemented with additional review papers, providing a comprehensive overview of the current status across all areas of phytochemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信